Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on SZ0104. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel rhodanine derivatives with potent Bcl-2 inhibition. Efficient synthesis route offers cost-effective API intermediate solutions for oncology drug development.